July 26, 2016 1:11 AM ET


Company Overview of Altor BioScience Corporation

Company Overview

Altor BioScience Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of immunotherapeutic agents for the treatment of cancer, viral infections, and inflammatory and autoimmune diseases. Its product candidates include ALT-801, a T-cell receptor-targeted immunotherapeutic for cancer; ALT-836, a monoclonal antibody-based tissue factor antagonist treatment of patients with acute respiratory distress syndrome and acute lung injury; and ALT-803, an IL-15 superagonist for patients with solid and hematological tumors/metastatic melanoma. The company’s product candidates also include ALT-802, a p53-TCR (T-cell receptors)/IgG1 fusion protein for treat...

2810 North Commerce Parkway

Miramar, FL 33025-3958

United States

Founded in 2002





Key Executives for Altor BioScience Corporation

Founder, Chief Executive Officer, President and Director
Chief Financial Officer
Age: 51
Vice Chairman and Chief Business Officer
Age: 67
Vice President of Research and Development
Consulting Medical Director and Member of Clinical Advisory Board
Compensation as of Fiscal Year 2016.

Altor BioScience Corporation Key Developments

Altor BioScience Corporation Partners with National Cancer Institute to Further Develop Altor’s ALT-803 and ALT-801 Cancer Immunotherapeutics

Altor BioScience Corporation announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI), an Institute of the National Institutes of Health (NIH). Under the CRADA, Altor will work with NCI to further develop its proprietary Interleukin-15 (IL-15) superagonist ALT-803 and single-chain T-cell-receptor/Interleukin-2 (IL-2) fusion protein ALT-801. In addition to the research to be conducted with NCI via this CRADA, these cytokine-based immunotherapy candidates are currently in various, unassociated Phase I and Phase II clinical trials for hematologic and solid tumor cancers.

Altor BioScience Corporation Announces Board Appointments

Altor BioScience Corporation announced that it has named Dr. Patrick Soon-Shiong, a well-known physician scientist and inventor of Abraxane as Chairman of the company’s Board of Directors. Mr. Fred Middleton, Managing Director of Sanderling Ventures, the company’s former Chairman and also the former CFO of Genentech, becomes Vice Chairman and will serve as the company’s Chief Business Officer. While continuing to serve on the company’s board, Mr. Middleton will take on an important strategic and operational role in leading the company’s business development activities. Dr. Soon-Shiong serves as Chairman of the Chan Soon-Shiong Family Foundation and Chairman and CEO of the Chan Soon-Shiong Institute of Molecular Medicine and Chairman and CEO of NantKwest. He currently co-chairs the CEO Council for Health and Innovation at the Bipartisan Policy Center and is a member of the Global Advisory Board of Bank of America.

Altor BioScience Corporation Presents at BIO-Europe 2015, Nov-02-2015

Altor BioScience Corporation Presents at BIO-Europe 2015, Nov-02-2015 . Venue: Munich, Germany.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

Private Placement
July 6, 2016

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Altor BioScience Corporation, please visit www.altorbioscience.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.